MSAC

Medicus Sciences Acquisition Corp.

Price

return (12m)

p/e

16.04

p/bv

-33.46

DIVIDEND YIELD

0.00%

MSAC price

Medicus Sciences Acquisition

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MSAC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals MSAC

Valuation

P/E

16.04

Sector -141.32

Industry 8.95

P/BV

-33.46

Sector -9.06

Industry 0.98

P/Revenue (PSR)

Sector -11.46

Industry 0.95

EV/EBITDA

Sector -999.04

Industry 13.86

EV/EBIT

Sector -144,991,159,736.88

Industry -48.40

P/EBITDA

23.27

Sector -98.13

Industry 3.83

P/EBIT

23.27

Sector -115.62

Industry -1.66

P/Total Assets

1.01

Sector 0.14

Industry 0.28

P/Net Current Assets

Sector -7.04

Industry -9.20

P/Working Capital

Sector -

Industry -0.59

EPS

0.63

Sector -9,594.05

Industry 4.34

BVPS

-0.30

Sector -26,074.95

Industry 26.22

Efficiency

Gross Margin

0.00%

Sector 0.21%

Industry 52.23%

EBITDA Margin

Sector -303.09%

Industry 18.30%

EBIT Margin

Sector -884,234.43%

Industry 10.70%

Operating Margin

0.00%

Sector -6.49%

Industry 11.21%

Net Profit Margins

0.00%

Sector -2.03%

Industry 8.61%

Asset Turnover

0.00

Sector 0.01

Industry 0.07

Profitability

ROE

-208.63%

Sector -1,330.10%

Industry 12.04%

ROA

6.31%

Sector -7.69%

Industry 2.64%

ROIC

Sector -11.32%

Industry -2.75%

Dividends

Dividend yield

0.00%

Sector 0.25%

Industry 0.48%

Payout

0.00%

Sector 5.45%

Industry 8.23%

Debt

Current Ratio

Sector -

Industry 1.04

Net Debt / EBITDA

Sector -154.11

Industry -0.04

Net Debt / EBIT

Sector -207,645,320,649.79

Industry -41.70

Net Debt / Equity

Sector -0.83

Industry 0.17

Gross Debt / Equity

Sector -0.23

Industry 0.62

Equity/Assets

-0.03

Sector -0.02

Industry 0.24

Liabilities/Assets

-0.03

Sector 0.36

Industry 0.72

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals MSAC

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MSAC Medicus Sciences Acquisition Corp.	$0.00	-	0.00%	16.04	-33.46	-208.63%	0.00%
HRZN Horizon Technology Finance Corporation	$4.65	-14.22%	23.90%	59.55	0.72	1.21%	-100.00%
ARCC Ares Capital Corporation	$19.41	1.43%	9.89%	14.52	1.00	6.91%	55.46%
GAIN Gladstone Investment Corporation	$15.86	19.91%	6.05%	3.82	0.98	25.53%	100.00%
BKCC BlackRock Capital Investment Corporation	$0.00	-	10.81%	9.46	0.86	9.04%	80.08%
RILYT B. Riley Financial Inc.	$20.75	52.53%	7.23%	1.36	3.15	231.65%	41.15%
WHF WhiteHorse Finance Inc.	$7.35	-2.16%	16.05%	20.27	0.63	3.09%	16.60%
RILYN B. Riley Financial Inc.	$25.22	26.94%	6.44%	1.65	3.83	231.65%	41.15%
BEN Franklin Resources Inc.	$32.83	44.28%	4.03%	14.73	1.30	8.80%	12.20%
FDUS Fidus Investment Corporation	$19.29	2.71%	11.46%	9.47	0.99	10.47%	67.26%
SLRC SLR Investment Corp.	$12.04	-16.44%	12.80%	8.90	0.67	7.51%	-100.00%
MSCI MSCI Inc.	$553.03	-3.04%	1.44%	29.77	-15.03	-50.49%	40.74%
BANX StoneCastle Financial Corp.	$20.89	6.01%	11.73%	4.22	0.85	20.19%	85.49%
GLAD Gladstone Capital Corporation	$19.33	-8.29%	9.46%	9.00	0.89	9.91%	65.72%
VRTS Virtus Investment Partners Inc.	$127.69	-28.82%	7.52%	7.34	0.90	12.25%	14.05%
TRIN Trinity Capital Inc.	$17.73	29.45%	13.56%	11.23	1.25	11.16%	58.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MSAC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Medicus Sciences Acquisition

Medicus Sciences Acquisition Corp.

Average Investor10 user rating

4.0 (0 people)

United States

6 years

Founded: 2020

2021

Time since IPO - 5 years

-

Employees

Medicus Sciences Acquisition Corp. (United States) is listed on the Nasdaq and has a market capitalization of $94.50 million, with shareholders equity totaling $-2.82 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Medicus Sciences Acquisition Corp. reported $- in revenue, generating net income of $5.89 million.

Key financial metrics include a P/E ratio of 16.04, a price-to-book (P/B) ratio of -33.46, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MSAC.

Market cap

$94.50 million

Net worth

$-2.82 million

$-2,824,511.00

Assets

$93.43 million

$93,431,852.00

Total Shares Outstanding

9.29 million

9,292,000

Average Daily Trading Volume

$53.74 Thousand

$53,743.22

Sector

Financial

Industry

Capital Markets

MSAC

MSAC revenue and profits

Financial Results MSAC

DRAG THE FRAME TO SEE MORE DATA

MSAC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BRK-A - Berkshire Hathaway

$761,693.26 2,88% (12M)

P/E

12.74

0.00%

ROE

11.45%

P/BV

1.46

BRK-B - Berkshire Hathaway

$508.53 3,18% (12M)

P/E

12.75

0.00%

ROE

11.46%

P/BV

1.46

JPM - JPMorgan

$346.62 12,24% (12M)

P/E

14.26

1.74%

ROE

17.37%

P/BV

2.48

SAN - Banco Santander SA ADR

$14.31 42,30% (12M)

P/E

4.31

1.41%

ROE

26.19%

P/BV

1.13

BAC - Bank of America

$57.91 13,27% (12M)

P/E

12.73

1.94%

ROE

10.97%

P/BV

1.40

C - Citigroup

$132.20 31,47% (12M)

P/E

13.62

1.87%

ROE

7.94%

P/BV

1.08

BCS - Barclays

$24.78 22,30% (12M)

P/E

7.91

2.47%

ROE

5.81%

P/BV

0.46

SNEX - StoneX Group

$67.34 63,36% (12M)

P/E

14.81

0.00%

ROE

18.53%

P/BV

2.74